Literature DB >> 17437531

An early age-related increase in the frequency of CD4+ Foxp3+ cells in BDC2.5NOD mice.

David C Thomas1, Richard J Mellanby, Jenny M Phillips, Anne Cooke.   

Abstract

The role of regulatory T cells (Treg) in maintaining tolerance to self has been intensively scrutinized, particularly since the discovery of Foxp3 as a Treg-specific transcription factor. The BDC2.5NOD transgenic mouse is an excellent model of immunoregulation because it has a very low incidence of diabetes despite a highly autoreactive T-cell repertoire. It has previously been shown that reactivity against islets decreases with age in BDC2.5NOD mice. Here we show that there is a markedly higher frequency of Foxp3(+) Treg in the CD4(+) subset of 16-20-week-old mice compared with 4- or 8-week-old mice. This phenomenon can be observed in the spleen, thymus, pancreatic draining lymph nodes and the pancreas itself. We show that this early age-related increase in the frequency of Foxp3(+) cells does not occur in wild-type NOD, BALB/c or C57BL/6 mice. Further, we show that, in contrast to some reports on Treg in wild-type NOD mice, the suppressive function of BDC2.5NOD Treg from 16- to 20-week-old mice is intact and comparable to that from 4- to 8-week-old mice both in vitro and in vivo. Our data offer insights into the long-term protection of BDC2.5NOD mice from diabetes and an explanation for the age-related decrease in anti-islet responses seen in BDC2.5NOD mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17437531      PMCID: PMC2265971          DOI: 10.1111/j.1365-2567.2007.02604.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  55 in total

1.  CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence.

Authors:  Piotr Trzonkowski; Ewa Szmit; Jolanta Myśliwska; Andrzej Myśliwski
Journal:  Clin Immunol       Date:  2006-03-20       Impact factor: 3.969

2.  T-lymphocyte clone specific for pancreatic islet antigen.

Authors:  K Haskins; M Portas; B Bradley; D Wegmann; K Lafferty
Journal:  Diabetes       Date:  1988-10       Impact factor: 9.461

3.  Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone.

Authors:  K Haskins; M McDuffie
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

4.  Genetic control of diabetes progression.

Authors:  A Gonzalez; J D Katz; M G Mattei; H Kikutani; C Benoist; D Mathis
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

5.  Following a diabetogenic T cell from genesis through pathogenesis.

Authors:  J D Katz; B Wang; K Haskins; C Benoist; D Mathis
Journal:  Cell       Date:  1993-09-24       Impact factor: 41.582

6.  Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.

Authors:  Sylvaine You; Géraldine Slehoffer; Samia Barriot; Jean-François Bach; Lucienne Chatenoud
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

Review 7.  Are regulatory T-cells linked with aging?

Authors:  Christian Dejaco; Christina Duftner; Michael Schirmer
Journal:  Exp Gerontol       Date:  2006-03-03       Impact factor: 4.032

8.  Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells.

Authors:  Xin Chen; Robin T Winkler-Pickett; Nicholas H Carbonetti; John R Ortaldo; Joost J Oppenheim; O M Zack Howard
Journal:  Eur J Immunol       Date:  2006-03       Impact factor: 5.532

9.  Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes.

Authors:  F Lühder; P Höglund; J P Allison; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1998-02-02       Impact factor: 14.307

10.  Where CD4+CD25+ T reg cells impinge on autoimmune diabetes.

Authors:  Zhibin Chen; Ann E Herman; Michael Matos; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2005-11-21       Impact factor: 14.307

View more
  17 in total

Review 1.  Immunosenescence: a key player in cancer development.

Authors:  Jingyao Lian; Ying Yue; Weina Yu; Yi Zhang
Journal:  J Hematol Oncol       Date:  2020-11-10       Impact factor: 17.388

2.  Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1/ PD-L1 pathway.

Authors:  Celine S Lages; Ian Lewkowich; Alyssa Sproles; Marsha Wills-Karp; Claire Chougnet
Journal:  Aging Cell       Date:  2010-10       Impact factor: 9.304

3.  A cluster of coregulated genes determines TGF-beta-induced regulatory T-cell (Treg) dysfunction in NOD mice.

Authors:  Anna Morena D'Alise; Ayla Ergun; Jonathan A Hill; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-04       Impact factor: 11.205

Review 4.  Considerations for successful cancer immunotherapy in aged hosts.

Authors:  V Hurez; Á S Padrón; R S Svatek; T J Curiel
Journal:  Clin Exp Immunol       Date:  2016-11-07       Impact factor: 4.330

5.  The Presence and Preferential Activation of Regulatory T Cells Diminish Adoptive Transfer of Autoimmune Diabetes by Polyclonal Nonobese Diabetic (NOD) T Cell Effectors into NSG versus NOD-scid Mice.

Authors:  Maximiliano Presa; Yi-Guang Chen; Alexandra E Grier; Edward H Leiter; Michael A Brehm; Dale L Greiner; Leonard D Shultz; David V Serreze
Journal:  J Immunol       Date:  2015-08-17       Impact factor: 5.422

6.  The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model.

Authors:  Kritika Kachapati; David E Adams; Yuehong Wu; Charles A Steward; Daniel B Rainbow; Linda S Wicker; Robert S Mittler; William M Ridgway
Journal:  J Immunol       Date:  2012-10-12       Impact factor: 5.422

7.  An alternative role for Foxp3 as an effector T cell regulator controlled through CD40.

Authors:  Gisela M Vaitaitis; Jessica R Carter; Dan M Waid; Michael H Olmstead; David H Wagner
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

8.  Accelerated type 1 diabetes induction in mice by adoptive transfer of diabetogenic CD4+ T cells.

Authors:  Gregory Berry; Hanspeter Waldner
Journal:  J Vis Exp       Date:  2013-05-06       Impact factor: 1.355

9.  A SNP in the Immunoregulatory Molecule CTLA-4 Controls mRNA Splicing In Vivo but Does Not Alter Diabetes Susceptibility in the NOD Mouse.

Authors:  Fabian Jakubczik; Ken Jones; Jennifer Nichols; William Mansfield; Anne Cooke; Nick Holmes
Journal:  Diabetes       Date:  2015-10-08       Impact factor: 9.461

Review 10.  How the ageing microenvironment influences tumour progression.

Authors:  Mitchell Fane; Ashani T Weeraratna
Journal:  Nat Rev Cancer       Date:  2019-12-13       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.